Proteomic analysis of oxidative modification in endothelial colony-forming cells treated by hydrogen peroxide

International Journal of Molecular Medicine

Volumn 29, Issue 6, 2012, Pages 1099-1105

  Wei, Jun ^a,b   Liu, Ying ^a   Chang, Ming ^a   Sun, Chong Ling ^b   Li, Da Wei ^a   Liu, Zhi Qiang ^a   Hu, Lin Sen ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Yichang Central People's Hospital   (China)

Author keywords

Endothelial colony forming cells; Endothelial progenitor cells; Oxidative stress; Proteomics

Indexed keywords

ACTIN; BIOLOGICAL MARKER; COFILIN 1; HYDROGEN PEROXIDE; ISOFORM A OF PRELAMIN A/C; PEROXIREDOXIN 4; T COMPLEX PROTEIN 1 SUBUNIT ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL STRAIN; CELL STRUCTURE; COLONY FORMING CELL; CYTOLOGY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTHELIAL CELLS; HYDROGEN PEROXIDE; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDANTS; OXIDATION-REDUCTION; PROTEINS; PROTEOMICS; RATS; ROSANILINE DYES;

EID: 84860517948     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.944     Document Type: Article

References (50)

1. Xu Q: Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am J Pathol 165: 1-10, 2004.
2. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
3. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM and Dimmeler S: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997. (Pubitemid 27087709)
5. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE and Dzau VJ: Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110: 2039-2046, 2004. (Pubitemid 39331919)
6. Hu Y, Davison F, Zhang Z and Xu Q: Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108: 3122-3127, 2003. (Pubitemid 38031802)
7. Xu Q, Zhang Z, Davison F and Hu Y: Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 93: e76-e86, 2003.
8. He T, Smith LA, Harrington S, Nath KA, Caplice NM and Katusic ZS: Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 35: 2378-2384, 2004. (Pubitemid 39311267)
9. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C and Taylor DA: Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108: 457-463, 2003. (Pubitemid 36935540)
10. + endothelial progenitor cells improves heart function and quality of life in patients with chronic post infarct heart insufficiency. Cardiovasc Revasc Med 11: 72-78, 2010.
11. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM and Dimmeler S: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890, 2001. (Pubitemid 32578123)
12. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003. (Pubitemid 36204953)
13. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M and Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005. (Pubitemid 41262334)
14. Griendling KK and FitzGerald GA: Oxidative stress and cardiovascular injury. Part II: animal and human studies. Circulation 108: 2034-2040, 2003. (Pubitemid 37337574)
15. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM and Dimmeler S: Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 104: 3591-3597, 2004. (Pubitemid 39564432)
16. He T, Peterson TE, Holmuhamedov EL, Terzic A, Caplice NM, Oberley LW and Katusic ZS: Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 24: 2021-2027, 2004. (Pubitemid 39482424)
17. Ingram DA, Krier TR, Mead LE, McGuire C, Prater DN, Bhavsar J, Saadatzadeh MR, Bijangi-Vishehsaraei K, Li F, Yoder MC and Haneline LS: Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 25: 297-304, 2007. (Pubitemid 46232783)
18. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT and Ingram DA: Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809, 2007. (Pubitemid 46348173)
19. Sieveking DP, Buckle A, Celermajer DS and Ng MK: Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 51: 660-668, 2008. (Pubitemid 351186872)
20. Popovic S, Arsenijevic N and Baskic D: In vitro assay for the quantitative measurement of apoptotic lymphocytes phagocytosis by peripheral blood monocytes. Acta Physiol Hung 93: 325-333, 2006. (Pubitemid 46019382)
21. Conrad CC, Choi J, Malakowsky CA, Talent JM, Dai R, Marshall P and Gracy RW: Identification of protein carbonyls after two-dimensional electrophoresis. Proteomics 1: 829-834, 2001. (Pubitemid 33587408)
22. Rafii S and Lyden D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-712, 2003. (Pubitemid 36749219)
23. Galasso G, Schiekofer S, Sato K, Shibata R, Handy DE, Ouchi N, Leopold JA, Loscalzo J and Walsh K: Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 98: 254-261, 2006.
24. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T and Isner JM: Statin therapy accelerates re- endothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 3017-3024, 2002. (Pubitemid 34693836)
25. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M and Nickenig G: Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-e24, 2003.
26. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J and Xu Q: Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis-results from a large population-based study. PLoS One 2: e975, 2007.
27. Ogita H and Liao J: Endothelial function and oxidative stress. Endothelium 11: 123-132, 2004. (Pubitemid 39207185)
28. Brackley KI and Grantham J: Activities of the chaperonin containing TCP-1 (CCT): implications for cell cycle progression and cytoskeletal organisation. Cell Stress Chaperones 14: 23-31, 2009.
29. Valpuesta JM, Martín-Benito J, Gómez-Puertas P, Carrascosa JL and Willison KR: Structure and function of a protein folding machine: the eukaryotic cytosolic chaperonin CCT. FEBS Lett 529: 11-16, 2002. (Pubitemid 35283904)
30. Horwich AL, Fenton WA, Chapman E and Farr GW: Two families of chaperonin: physiology and mechanism. Annu Rev Cell Dev Biol 23: 115-145, 2007.
31. Lewis SA, Tian G and Cowan NJ: The alpha- and beta-tubulin folding pathways. Trends Cell Biol 7: 479-484, 1997.
32. Grant DS, Lelkes PI, Fukuda K and Kleinman HK: Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev Biol 27A: 327-336, 1991.
33. Dalle-Donne I, Rossi R, Giustarini D, Gagliano N, Lusini L, Milzani A, Di Simplicio P and Colombo R: Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med 31: 1075-1083, 2001. (Pubitemid 33000129)
34. Samstag Y, Eibert SM, Klemke M and Wabnitz GH: Actin cytoskeletal dynamics in T lymphocyte activation and migration. J Leukoc Biol 73: 30-48, 2003. (Pubitemid 36125673)
35. Klemke M, Wabnitz GH, Funke F, Funk B, Kirchgessner H and Samstag Y: Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity 29: 404-413, 2008.
36. Klamt F, Zdanov S, Levine RL, Pariser A, Zhang Y, Zhang B, Yu LR, Veenstra TD and Shacter E: Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat Cell Biol 11: 1241-1246, 2009.
37. Wabnitz GH, Goursot C, Jahraus B, Kirchgessner H, Hellwig A, Klemke M, Konstandin MH and Samstag Y: Mitochondrial translocation of oxidized cofilin induces caspase-independent necrotic-like programmed cell death of T cells. Cell Death Dis 1: e58, 2010.
38. Goldman RD, Gruenbaum Y, Moir RD, Shumaker DK and Spann TP: Nuclear lamins: building blocks of nuclear architecture. Genes Dev 16: 533-547, 2002. (Pubitemid 34212486)
39. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R and Collins FS: Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 101: 8963-8968, 2004. (Pubitemid 38781594)
40. Bridger JM and Kill IR: Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol 39: 717-724, 2004. (Pubitemid 38586812)
41. Scaffidi P and Misteli T: Lamin A-dependent nuclear defects in human aging. Science 312: 1059-1063, 2006.
42. Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M and Bennett M: Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 99: 156-164, 2006. (Pubitemid 44297039)
43. McClintock D, Gordon LB and Djabali K: Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci USA 103: 2154-2159, 2006. (Pubitemid 43271639)
44. Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD and Collins FS: Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 102: 12879-12884, 2005. (Pubitemid 41282816)
45. Ragnauth CD, Warren DT, Liu Y, McNair R, Tajsic T, Figg N, Shroff R, Skepper J and Shanahan CM: Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 121: 2200-2210, 2010.
46. Wang L, Li SJ, Sidhu A, Zhu L, Liang Y, Freedman RB and Wang CC: Reconstitution of human Ero1-Lalpha/protein-disulfide isomerase oxidative folding pathway in vitro. Position-dependent differences in role between the a and a' domains of protein-disulfide isomerase. J Biol Chem 284: 199-206, 2009.
47. Rhee SG, Chae HZ and Kim K: Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005.
48. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS and Woo HA: Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 17: 183-189, 2005. (Pubitemid 40380942)
49. Iuchi Y, Okada F, Tsunoda S, Kibe N, Shirasawa N, Ikawa M, Okabe M, Ikeda Y and Fujii J: Peroxiredoxin 4 knockout results in elevated spermatogenic cell death via oxidative stress. Biochem J 419: 149-158, 2009.
50. 2 produced during disulphide formation. J Cell Sci 123: 2672-2679, 2010.